Dr. Julie Palmer – The Karin Grunebaum Professor in Cancer Research at Boston University Chobanian & Avedisian School of Medicine, recently had her work published in Environmental Research Journal.
Research on lung cancer leads to changes in national guidelines for screening eligibility.
Because Karin Grunebaum died at age 39 from an unknown primary site malignancy, the overriding objective of the Karin Grunebaum Cancer Research Foundation is the eradication of all types of cancer. The Foundation's original Declaration of Trust, written in 1958, mandates that the Foundation's funds be exclusively used for "...aiding research in and study of the cause, treatment and cure of cancer."
The Foundation's Trustees firmly believe that the eradication of cancer will only occur through successful research accomplishments which are followed by successful practical/commercial application. Thus, the Foundation has chosen to invest its funds directly in dedicated cancer researchers in hope of helping them achieve significant accomplishments to eliminate all types of carcinomas and thereby eradicate each and every type of cancer.
Trustee
M.D., Ph.D.
Chief, MGB Division of Classical Hematology; Clinical Director, MGB Special Coagulation Laboratory; Associate Professor, Harvard Medical School
Director, Melanoma Surgery Program,
Massachusetts General Hospital;
Associate Professor, Harvard Medical School;
Associate Member, Broad Institute of MIT and Harvard
Karin Grunebaum Professor in Cancer Research, Emeritus,
Boston University School of Medicine
Harvard Medical School Dean for Basic Science and Graduate Education and Special Advisor for Global Programs;
Professor of Biological Chemistry and Molecular Pharmacology;
George R. Minot Professor of Medicine;
Senior Physician, Brigham and Women's Hospital and Dana-Farber Cancer Institute
Virginia and D.K. Ludwig Professor of Cancer Research and Teaching, Harvard Medical School; Senior Advisor to the Director, National Cancer Institute.
Karin's daughter.
Karin's grand-son
Professor, Departments of Medicine and Pathology, Boston University School of Medicine
Karin Grunebaum Professor in Cancer Research, Boston University School of Medicine;
Director, Slone Epidemiology Center;
Co-Director, Boston University - Boston Medical Center Cancer Center
Trustee
.jpg)
Ph.D.
Dean ad interim; Associate Dean Faculty Affairs; Carolann S. Najarian, M.D. Professor & Chair of Medical Sciences & Education; Professor of Dermatology, BU Chobanian & Avedesian School of Medicine
Trustee
Karin's grand-daughter; Director of Communications and Secretary Pro Tem
Karin's son; Foundation Chairperson
Karin's grand-daughter; Foundation Secretary
Karin's daughter. Foundation Treasurer
The Foundation is very proud of the success achieved by our Fellows who have been working and teaching at some of the most prestigious and front-line cancer research facilities in the world, including: Adaptive Biotechnologies, AMGEN Corp, Celgene Corp., City of Hope, Cleveland Clinic, Dana-Farber Cancer Institute, Dartmouth-Hitchcock Medical Center, Duke University Health, George Washington University School of Medicine, Immune Design, Johns Hopkins, Massachusetts General Hospital, M.D. Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Merck & Co., Mersana Therapeutics, Mount Sinai School of Medicine, NYU Langone Medical Center, Oncternal Therapeutics, Seattle Childrens' Hospital, Siteman Cancer Center, SLJ Consulting, Stanford University Cancer Center, Takeda Pharmaceutical, UCLA Medical Center, University of Alabama School of Medicine, University of Arizona College of Medicine, University of California: (Davis), (Irvine), (Los Angeles) and (San Francisco), University of Maryland School of Medicine, University of Miami School of Medicine, University of Pennsylvania School of Medicine, University ot Texas Health Science Center, University of Vermont Medical School, Vanderbilt University Medical Center, Weill Cornell Medical Center, Yale Cancer Center and Zyngenia Corporation, in addition to our sponsored institutions of Harvard Medical School and Boston University School of Medicine.
Whether you want to eliminate taxes or benefit from an increased income stream, there is a gift to fit every objective. Please review our Benefits of Giving to charitable organizations to learn how you can give as well as receive.
If you are interested in the institutions where our Fellows teach, you can review their Universities here:
Fellowships are available to junior faculty members at Harvard Medical School and the Boston University School of Medicine. If you are interested in applying to become a Karin Grunebaum Fellow, please use the following links to the institutions.
We believe that the eradication of cancer will only occur through successful research, which is followed by successful practical/commercial applications
Follow us on Twitter to stay up to date on what we are doing…
